Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Molecular mechanisms of cadmium-induced fibroblast growth factor 23 upregulation in osteoblast-like cells.

Kido S, Fujihara M, Nomura K, Sasaki S, Mukai R, Ohnishi R, Kaneko I, Segawa H, Tatsumi S, Izumi H, Kohno K, Miyamoto K.

Toxicol Sci. 2014 Jun;139(2):301-16. doi: 10.1093/toxsci/kfu043. Epub 2014 Mar 10.

PMID:
24614234
[PubMed - indexed for MEDLINE]
2.

A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.

Ichikawa S, Austin AM, Gray AK, Econs MJ.

J Bone Miner Res. 2012 Feb;27(2):453-60. doi: 10.1002/jbmr.544.

PMID:
22006791
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Pathogenic role of Fgf23 in Hyp mice.

Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD.

Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E38-49. Epub 2006 Jan 31.

PMID:
16449303
[PubMed - indexed for MEDLINE]
Free Article
4.

Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.

Rhee Y, Bivi N, Farrow E, Lezcano V, Plotkin LI, White KE, Bellido T.

Bone. 2011 Oct;49(4):636-43. doi: 10.1016/j.bone.2011.06.025. Epub 2011 Jun 25.

PMID:
21726676
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD.

J Am Soc Nephrol. 2006 May;17(5):1305-15. Epub 2006 Apr 5.

PMID:
16597685
[PubMed - indexed for MEDLINE]
Free Article
6.

Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.

Liu S, Tang W, Zhou J, Vierthaler L, Quarles LD.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1636-44. Epub 2007 Sep 11.

PMID:
17848631
[PubMed - indexed for MEDLINE]
Free Article
7.

1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.

Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, Collins JF, Haussler MR, Ghishan FK.

Am J Physiol Gastrointest Liver Physiol. 2005 Dec;289(6):G1036-42. Epub 2005 Jul 14.

PMID:
16020653
[PubMed - indexed for MEDLINE]
Free Article
8.

[Fibroblast growth factor 23 mediates the phosphaturic actions of cadmium].

Kido S, Fujihara M, Nomura K, Sasaki S, Shiozaki Y, Segawa H, Tatsumi S, Miyamoto K.

Nihon Eiseigaku Zasshi. 2012;67(4):464-71. Review. Japanese.

PMID:
23095356
[PubMed - indexed for MEDLINE]
Free Article
9.

Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice.

Miyagawa K, Yamazaki M, Kawai M, Nishino J, Koshimizu T, Ohata Y, Tachikawa K, Mikuni-Takagaki Y, Kogo M, Ozono K, Michigami T.

PLoS One. 2014 Apr 7;9(4):e93840. doi: 10.1371/journal.pone.0093840. eCollection 2014.

PMID:
24710520
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.

Martin A, Liu S, David V, Li H, Karydis A, Feng JQ, Quarles LD.

FASEB J. 2011 Aug;25(8):2551-62. doi: 10.1096/fj.10-177816. Epub 2011 Apr 20.

PMID:
21507898
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Autocrine/paracrine action of vitamin D on FGF23 expression in cultured rat osteoblasts.

Tang WJ, Wang LF, Xu XY, Zhou Y, Jin WF, Wang HF, Gao J.

Calcif Tissue Int. 2010 May;86(5):404-10. doi: 10.1007/s00223-010-9355-2. Epub 2010 Mar 31.

PMID:
20354682
[PubMed - indexed for MEDLINE]
12.

Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.

Ichikawa S, Sorenson AH, Austin AM, Mackenzie DS, Fritz TA, Moh A, Hui SL, Econs MJ.

Endocrinology. 2009 Jun;150(6):2543-50. doi: 10.1210/en.2008-0877. Epub 2009 Feb 12.

PMID:
19213845
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Fibroblast growth factor 23 mediates the phosphaturic actions of cadmium.

Aranami F, Segawa H, Furutani J, Kuwahara S, Tominaga R, Hanabusa E, Tatsumi S, Kido S, Ito M, Miyamoto K.

J Med Invest. 2010 Feb;57(1-2):95-108.

PMID:
20299748
[PubMed - indexed for MEDLINE]
Free Article
14.

Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro.

Xiao L, Esliger A, Hurley MM.

J Bone Miner Res. 2013 Jan;28(1):35-45. doi: 10.1002/jbmr.1721.

PMID:
22836867
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Bone formation regulates circulating concentrations of fibroblast growth factor 23.

Samadfam R, Richard C, Nguyen-Yamamoto L, Bolivar I, Goltzman D.

Endocrinology. 2009 Nov;150(11):4835-45. doi: 10.1210/en.2009-0472. Epub 2009 Oct 9.

PMID:
19819968
[PubMed - indexed for MEDLINE]
16.

Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis.

Tagliabracci VS, Engel JL, Wiley SE, Xiao J, Gonzalez DJ, Nidumanda Appaiah H, Koller A, Nizet V, White KE, Dixon JE.

Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5520-5. doi: 10.1073/pnas.1402218111. Epub 2014 Mar 26.

PMID:
24706917
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6.

Saini RK, Kaneko I, Jurutka PW, Forster R, Hsieh A, Hsieh JC, Haussler MR, Whitfield GK.

Calcif Tissue Int. 2013 Apr;92(4):339-53. doi: 10.1007/s00223-012-9683-5. Epub 2012 Dec 22.

PMID:
23263654
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

1alpha,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro.

Yamamoto R, Minamizaki T, Yoshiko Y, Yoshioka H, Tanne K, Aubin JE, Maeda N.

J Endocrinol. 2010 Sep;206(3):279-86. doi: 10.1677/JOE-10-0058. Epub 2010 Jun 8.

PMID:
20530653
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.

Stubbs JR, He N, Idiculla A, Gillihan R, Liu S, David V, Hong Y, Quarles LD.

J Bone Miner Res. 2012 Jan;27(1):38-46. doi: 10.1002/jbmr.516.

PMID:
22031097
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR).

Cheng X, Vispute SG, Liu J, Cheng C, Kharitonenkov A, Klaassen CD.

Toxicol Appl Pharmacol. 2014 Jul 1;278(1):65-71. doi: 10.1016/j.taap.2014.04.013. Epub 2014 Apr 24.

PMID:
24769090
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk